Literature DB >> 34183794

Randomized double-blind trial of wipes containing terpinen-4-ol and hyaluronate versus baby shampoo in seborrheic blepharitis patients.

Ceyhun Arici1, Burak Mergen2, Ayse Yildiz-Tas3, Hrisi Bahar-Tokman4, Edip Tokuc4, Yesim Ozturk-Bakar4, Zekayi Kutlubay5, Afsun Sahin3.   

Abstract

PURPOSE: To investigate the efficacy of lid wipes (LWs) containing terpinen-4-ol and sodium hyaluronate (Hy-ter®) for the treatment of seborrheic blepharitis compared to baby shampoo (BS).
METHODS: This randomized, double-blind, active control, parallel group, multicentre clinical trial included 48 eyes of 48 patients with seborrheic blepharitis who were randomly divided into two treatment arms (1:1, n = 24) using block randomization. LWs or BS were prescribed twice a day for 8 weeks followed by a discontinuation period of 4 weeks. Change in Blepharitis Symptom measure (BLISS), Schirmer's test, tear breakup time (TBUT), noninvasive TBUT (NI-TBUT), ocular surface disease index (OSDI) score, corneal and conjunctival staining, meibography, and Demodex count at different visits (Baseline, 4th, 8th, and 12th week) were the main outcome measures.
RESULTS: The baseline values of both groups were similar (p > 0.05). Despite high clinical efficacy in both treatment arms, patients using LWs showed a lower BLISS score at the 8th and 12th-week visit (1.9 ± 2.2 versus 7.2 ± 6.6, p = 0.003; 4.0 ± 1.3 versus 5.8 ± 6.3, p = 0.026). NI-TBUT showed a significant increase starting from the 4th week for patients using LWs and 8th week for patients using BS. Both treatment modalities caused a reduction in the Demodex count after 4 weeks of treatment (p < 0.001). The treatment withdrawal did not cause any recurrence in both treatment arms.
CONCLUSION: BS or LWs containing Hy-ter® can be used with good efficacy for the treatment of seborrheic blepharitis. However, LWs may provide a better symptomatic relief compared to BS after 8 weeks of treatment.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34183794      PMCID: PMC8956696          DOI: 10.1038/s41433-021-01642-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  28 in total

1.  Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis.

Authors:  Valentin Navel; Aurélien Mulliez; Cédric Benoist d'Azy; Julien S Baker; Jean Malecaze; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  Ocul Surf       Date:  2019-06-20       Impact factor: 5.033

Review 2.  Blepharitis Preferred Practice Pattern®.

Authors:  Guillermo Amescua; Esen K Akpek; Marjan Farid; Francisco J Garcia-Ferrer; Amy Lin; Michelle K Rhee; Divya M Varu; David C Musch; Steven P Dunn; Francis S Mah
Journal:  Ophthalmology       Date:  2018-10-23       Impact factor: 12.079

3.  Randomized trial of topical periocular castor oil treatment for blepharitis.

Authors:  Alex Muntz; Emma Sandford; Marna Claassen; Lauren Curd; Alice K Jackson; Grant Watters; Michael T M Wang; Jennifer P Craig
Journal:  Ocul Surf       Date:  2020-05-15       Impact factor: 5.033

4.  Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum.

Authors:  Doaa Abdel-Badie Salem; Atef El-Shazly; Nairmen Nabih; Youssef El-Bayoumy; Sameh Saleh
Journal:  Int J Infect Dis       Date:  2013-01-05       Impact factor: 3.623

5.  Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes.

Authors:  P H Hart; C Brand; C F Carson; T V Riley; R H Prager; J J Finlay-Jones
Journal:  Inflamm Res       Date:  2000-11       Impact factor: 4.575

6.  Role of cell-mediated immunity to staphylococci in blepharitis.

Authors:  L Ficker; M Ramakrishnan; D Seal; P Wright
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

7.  Pilocarpine gel for the treatment of demodicosis--a case series.

Authors:  G W Fulk; B Murphy; M D Robins
Journal:  Optom Vis Sci       Date:  1996-12       Impact factor: 1.973

8.  The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis.

Authors:  Orla Murphy; Veronica O'Dwyer; Aoife Lloyd-McKernan
Journal:  Cont Lens Anterior Eye       Date:  2017-10-23       Impact factor: 3.077

9.  Classification of chronic blepharitis.

Authors:  J P McCulley; J M Dougherty; D G Deneau
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

Review 10.  Diagnosis and management of blepharitis: an optometrist's perspective.

Authors:  Christopher M Putnam
Journal:  Clin Optom (Auckl)       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.